Amphastar Nanjing Pharmaceuticals Inc.
We are professional supplier of Bio-similars,Generic Peptides,Other APIs,Other Generic APIs.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Product Introduction
Insulin Aspart (CAS No.: 116094-23-6) is
homologous with regular human insulin with the exception of a single
substitution of the amino acid proline by aspartic acid in position B28. DMF to
be filed in third quarter, 2017
Indication
Improve glycemic control in patients with
diabetes mellitus
Package
Package size: ≤0.4KG
Inner package: LDPE bags
Outer Package: Aluminum plastic compound bag& Aluminum Tin.
Product Introduction
Insulin Aspart (CAS No.: 116094-23-6) is
homologous with regular human insulin with the exception of a single
substitution of the amino acid proline by aspartic acid in position B28. DMF to
be filed in third quarter, 2017
Indication
Improve glycemic control in patients with
diabetes mellitus
Package
Package size: ≤0.4KG
Inner package: LDPE bags
Outer Package: Aluminum plastic compound bag& Aluminum Tin.
